Showing results (1091-1100 of 10,559) with videos related to

Sort By:
Pageof 1,056
Thrombosis Research|May 13, 2014
Combination of antithrombin and recombinant thrombomodulin modulates neutrophil cell-death and decreases circulating DAMPs levels in endotoxemic ratsToshiaki Iba, Takahiro Miki, Naoyuki Hashiguchi, et al.
Thrombosis Research|May 13, 2014
New insights in heparin-induced thrombocytopenia by the use of fluid-phase assays to detect specifically platelet factor 4/heparin complex antibodies and antibody-secreting cellsAnnika Schulze, Inga Jensch, Krystin Krauel, et al.
Thrombosis Research|April 29, 2014
Impact of short periods with worsened or improved INR control on life expectancy and QALYs in patients with atrial fibrillationEva Lesén, Ingela Björholt, Ase Björstad, et al.
Thrombosis Research|April 16, 2014
Platelet activation patterns are different in mouse models of diabetes and chronic inhibition of nitric oxide synthesisMarcin Rozalski, Hassan Kassassir, Karolina Siewiera, et al.
Thrombosis Research|April 16, 2014
Clonal populations of hematopoietic cells with paroxysmal nocturnal hemoglobinuria phenotype in patients with splanchnic vein thrombosisWalter Ageno, Francesco Dentali, Valerio De Stefano, et al.
Thrombosis Research|April 16, 2014
Pharmacodynamics assessment of Bemiparin after multiple prophylactic and single therapeutic doses in adult and elderly healthy volunteers and in subjects with varying degrees of renal impairmentSalvador Rico, Rosa-María Antonijoan, Maria Rosa Ballester, et al.
Thrombosis Research|April 16, 2014
Symptomatic thromboembolic events in patients treated with intravenous-immunoglobulins: results from a retrospective cohort studyElena Ramírez, José A Romero-Garrido, Eduardo López-Granados, et al.
Thrombosis Research|March 12, 2014
Direct microscopic monitoring of initial and dynamic clot lysis using plasmin or rt-PA in an in vitro flow systemNina Bizjak, Franci Bajd, Jernej Vidmar, et al.
Thrombosis Research|March 4, 2021
Recombinant ADAMTS13 reduces abnormally up-regulated von Willebrand factor in plasma from patients with severe COVID-19Peter L Turecek, Rachel C Peck, Savita Rangarajan, et al.
Thrombosis Research|March 12, 2021
5-year outcomes from rivaroxaban therapy in atrial fibrillation: Results from the Dresden NOAC RegistryLuise Tittl, Sandra Marten, Christiane Naue, et al.
Pageof 1,056